Corteva agriscience signs agreement to acquire stoller group, one of the largest independent biologicals companies in the industry

Stoller brings global sales of +$400 million and presence in over 60 countries  reinforces commitment to driving value for farmers through innovative, sustainable solutions corteva's second biologicals transaction since completion of strategic portfolio reviews indianapolis and houston , nov. 30, 2022 /prnewswire/ -- corteva, inc. (nyse: ctva) and stoller group, inc. ("stoller") today announced that corteva has signed a definitive agreement to acquire houston-based stoller, one of the largest independent biologicals companies in the industry.  with operations and sales in more than 60 countries and 2022 forecasted revenues of more than $400 million, stoller brings immediate scale and profitability, with ebitda margins that will be accretive to corteva.
CTVA Ratings Summary
CTVA Quant Ranking